Peptide Therapeutics intermediate
Milestone 011: Oligopeptide Research Reference
2003: First anti-TNF biologic (adalimumab) approved. Opens era of biologic immunotherapy. This peptide or oligopeptide is studied for its biological activity...
By Encyclopeptide Editorial | 1 min read
milestone-011 peptide research
Overview
2003: First anti-TNF biologic (adalimumab) approved. Opens era of biologic immunotherapy.
Clinical Significance
This topic has important implications for peptide research and clinical applications.
References
- Encyclopeptide Database. “Milestone 011” monograph. encyclopeptide.com.
Test Your Knowledge
Reinforce what you learned about Milestone 011: Oligopeptide Research Reference with interactive quizzes on Wikipept.
Take a Quiz on Wikipept